Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. [electronic resource]
Producer: 20130312Description: 229-34 p. digitalISSN:- 1468-2060
- Adalimumab
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- drug therapy
- Etanercept
- Herpes Zoster -- epidemiology
- Humans
- Immunoglobulin G -- adverse effects
- Incidence
- Infliximab
- Middle Aged
- Receptors, Tumor Necrosis Factor
- Risk Factors
- Skin Diseases, Infectious -- epidemiology
- Soft Tissue Infections -- epidemiology
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.